# FES Walking Systems and Devices for Spinal Cord Injury: Comprehensive Research Review

## Table of Contents
1. [Parastep I System](#parastep-i-system)
2. [Cleveland FES Center Research Systems](#cleveland-fes-center-research-systems)
3. [Vienna FES System](#vienna-fes-system)
4. [Commercial Exoskeletons](#commercial-exoskeletons)
5. [Other FES Walking Systems](#other-fes-walking-systems)
6. [Novel Research Approaches](#novel-research-approaches)
7. [Key Limitations and Challenges](#key-limitations-and-challenges)
8. [References](#references)

---

## 1. Parastep I System

### Overview
**Manufacturer:** Sigmedics Inc.
**Device Type:** Surface FES walking system
**Target Population:** Spinal cord injured patients (C6-T12)

### FDA Approval
- **Status:** FDA Approved
- **PMA Number:** P900038
- **Approval Date:** April 20, 1994[^1][^2]
- **Distinction:** Only noninvasive functional walking neuromuscular stimulation device to receive FDA premarket approval[^3][^4]

### Indications for Use
Approved to "enable appropriately selected skeletally mature spinal cord injured patients (level C6 to T12) to stand and attain limited ambulation and/or take steps, with assistance if required, following a prescribed period of physical therapy training in conjunction with rehabilitation management of spinal cord injury."[^3]

### Technical Specifications

#### System Components
- Microcomputer controlled neuromuscular stimulation unit
- Battery activated power pack with re-charger
- Surface applied skin electrodes
- Power and electrode cables
- Control and stability walker with finger activated control switches[^5]

#### Stimulation Parameters
- **Channels:** 6 channels (bilateral stimulation)[^6]
- **Electrode Pairs:** 6 pairs of surface electrodes
- **Target Muscles:**
  - Bilateral quadriceps (knee extension)
  - Bilateral peroneal nerves (hip flexion via flexion withdrawal reflex)
  - Bilateral glutei (trunk stability)

#### Control Method
- **Type:** Open-loop control[^7][^8]
- **Interface:** Manual push-button control on walker handles
- **User Input:** User presses buttons on left and right handles to trigger sequential left and right steps[^5]
- **Activation:** Produces stride by activating quadriceps of one leg while initiating flexion withdrawal reflex in opposite leg

### Clinical Outcomes

#### Success Rate
- **Chaplin (1996):** Largest study with 91 patients
  - 84 patients (92%) able to take steps
  - 31 patients (34%) able to eventually ambulate without assistance from another person[^1]

#### Walking Distance
- After adequate training, approximately 400 paraplegic subjects could ambulate 6-9m with the Parastep system
- Some users achieved stepping up to 800m[^7]
- **Brissot et al. (2000):** 13 paraplegics could ambulate 2-350m after average of 20 training sessions[^7]

### Training Requirements
- 32 sessions of physical therapy required[^1]
- Includes instruction on system use and gait training
- Training provided by hospital-based physical therapists who completed Sigmedics clinical training program
- Training included with system purchase

### Medicare Coverage
- **Effective Date:** April 1, 2003
- **Coverage Type:** National Coverage Determination by CMS
- **HCPCS Codes:**
  - Code 97116: Physical therapy training services
  - Code E0764: Equipment acquisition
- **Coverage Amount:** Medicare covers approximately 80% of equipment acquisition costs[^5]
- **Patient Responsibility:** 20% copay plus any additional costs beyond Medicare allowance

### Pricing
- Specific retail pricing not publicly disclosed in current sources
- Over 20-year period (1994-2014), approximately 550 units sold[^5]
- **Contact for Pricing:**
  - Email: info@sigmedics.com
  - Phone: 212-729-1878

### Why Open-Loop Control?

#### Rationale
The Parastep system uses open-loop control for several practical reasons:

1. **Simplicity and Reliability:** Open-loop systems are straightforward and reliable to implement[^7][^8]
2. **Ease of Use:** Faster and easier setup compared to closed-loop systems[^8]
3. **Surface Electrodes:** Surface stimulation systems are easier to don/doff than implanted systems[^9]
4. **Technology Era:** Developed in early 1990s when sensor technology was less advanced and more expensive

#### Limitations of Open-Loop Approach
- Requires continuous user attention and frequent button pressing[^7][^8]
- No automatic adjustment for muscle fatigue or changing conditions[^9][^10]
- Mistiming of stimulation can result in abnormal muscle synchronization within gait cycle[^7]
- May be inopportune considering hands need firm grip on frame handles[^7]
- Error in pressing command could result in fall[^7]
- No feedback about actual limb position or movement state[^7]

### Key Limitations
- Cannot directly stimulate hip flexors (relies on flexion withdrawal reflex)[^11]
- Rapid onset of muscle fatigue[^12]
- Requires walker or crutches for support and balance
- Limited walking speeds and distances
- Extensive training period required (32 sessions)
- Only 34% of users achieved independent ambulation[^1]

---

## 2. Cleveland FES Center Research Systems

### Overview
**Institution:** Cleveland FES Center (consortium of Cleveland VA Medical Center, Case Western Reserve University, and MetroHealth Medical Center)
**Established:** 1991[^13]
**Key Researchers:** Dr. Hunter Peckham, Dr. Ronald J. Triolo, Dr. Rudi Kobetic

### Networked Neuroprosthetic (NNP) System

#### System Architecture
Developed by Dr. Hunter Peckham's group at Case Western Reserve University, based on distributed "neuroprosthetic building blocks"[^14][^15]

#### Key Components
1. **Power Module**
   - Provides power distribution to all modules
   - Implanted power source recharged via transcutaneous inductive link
   - Incorporates bidirectional wireless link for monitoring and programming[^14]

2. **Actuator Modules**
   - Target-based: Muscle Stimulators, Nerve Stimulators[^14]

3. **Sensor Modules**
   - Source-based: Biopotential sensors, Transducers[^14]

4. **Network Cable**
   - Provides power and high-speed data connection between modules[^14]

5. **Electrodes**
   - Application-specific stimulating and recording electrodes[^14]

#### Key Advantages
- Scalable from simple to complex applications[^14][^15]
- Tailored to individual's needs
- Multiple disabilities can be addressed in single individual
- Upgradeable to accommodate future technologies
- Adaptable to changing user needs
- System can be expanded and upgraded after initial implantation without component removal[^14][^15]

### Implantable Electrode Technologies

#### 1. Epimysial Electrodes
- **Design:** Silicone-encased cable terminating onto 4mm diameter platinum-iridium disc
- **Substrate:** Medical-grade dacron-reinforced silicone substrate
- **Placement:** Sewn onto surface of muscle[^16]

#### 2. Intramuscular Electrodes
- **Stimulating Element:** 316 stainless steel wound around distal end of lead
- **Anchor:** Polypropylene anchor secures electrode in muscle[^16]

#### 3. Nerve Cuff Electrodes

**Self-Spiraling Nerve Cuff:**
- Conforms to natural circumference of nerve
- Single or multiple platinum-foil contacts (2-4+)
- Can be wired for monopolar or multipolar configuration[^16]

**Composite Flat Interface Nerve Electrode (C-FINE):**
- Variable-stiffness cuff electrode
- Gently shapes nerve for closer contact to fascicles
- Multiple platinum-foil contacts (4-16+)
- Enhanced selectivity for fascicle-specific stimulation[^16]

### Implantable Stimulator Systems

#### IST-12 (Implantable Stimulator-Telemeter)
**Specifications:**
- **Channels:** 12 stimulation channels[^17]
- **Sensing:** 2 myoelectric signal (MES) channels[^17]
- **MES Circuitry:** Two-channel multiplexer, preamplifier, variable gain amplifier/bandpass filter, full-wave rectifier, bin integrator[^17]
- **Communication:** Inductive RF link providing power and two-way transcutaneous communication[^18]
- **Packaging:** Biocompatible hermetic packaging with in-line connectors for long-term implantation[^18]
- **Primary Application:** Upper extremity function restoration in tetraplegia (C6 level)[^17][^18]

### Walking System Clinical Outcomes

#### 16-Channel Implanted System

**Performance Range:**
- Walking speeds: 0.1 m/s (slow step-to gait) to 0.5 m/s (smooth reciprocal gait)[^19][^20]
- **Best Subject Performance:**
  - Speed: 0.4 m/s (average)
  - Cadence: 58 steps/min
  - Stride length: 0.8 m
  - Maximum repeatable distance: 34 m[^19][^20]

**Muscle Selection (16 channels):**
- Erector spinae (trunk extension)
- Gluteus maximus (hip extension)
- Posterior adductor magnus (hip extension)
- Hamstrings (hip extension)
- Tensor fasciae latae (hip flexion)
- Sartorius or iliopsoas (hip flexion)
- Vastus lateralis/intermedius (knee extension)
- Tibialis anterior/peroneus longus (ankle dorsiflexion)[^19]

#### 8-Channel Implanted System

**Case Study (Hardin et al., 2007):**[^21][^22]

**Patient Profile:**
- Incomplete SCI (ASIA grade C, cervical level 6-7)
- Could stand volitionally but not step before implantation

**Electrode Placement (bilateral):**
- Iliopsoas
- Vastus intermedius and lateralis
- Tensor fasciae latae
- Tibialis anterior
- Peroneus longus

**Outcomes (after 12-week training):**
- Maximum walking distance: 14 m → 309 m (22x increase)
- Maximum walking speed: 0.02 m/s → 0.20 m/s (10x increase)
- Physiological cost index: 44.4 beats/m → 8.6 beats/m (5x reduction)
- System well-tolerated, reliable, and enabled limited community ambulation[^21][^22]

**8-Channel Limitations:**
- Most patterns resulted in scissoring or insufficient hip flexion
- Maximum speed: 0.1 m/s
- Cadence: 22 steps/min
- Stride length: <0.3 m
- Prevented forward progression in many cases[^20]

### Implanted vs Surface Electrode Systems

#### Advantages of Implanted Systems
- Can directly stimulate hip flexor muscles (iliopsoas, sartorius)[^11][^23]
- More selective muscle recruitment
- Better repeatability and consistency
- No daily electrode placement required
- More cosmetically acceptable
- Better contact stability (no electrode shifting)

#### Disadvantages of Implanted Systems
- Requires surgery with associated risks
- More complex to modify or troubleshoot
- Higher initial cost
- Limited availability (research only, not commercially available)[^4]
- Longer setup and implementation time[^8]

### Regulatory Status
- **Current Status:** Research/experimental only
- **FDA Approval:** Not FDA approved for commercial use
- **Clinical Trials:** Available at Cleveland FES Center and affiliated sites
- **Access:** ClinicalTrials.gov and SCITrials.org for current studies[^24]

### Key Publications

1. **Kobetic et al. (1997):** "Muscle selection and walking performance of multichannel FES systems for ambulation in paraplegia." IEEE Trans Rehabil Eng, 5(1): 23-29.[^19]

2. **Hardin et al. (2007):** "Walking after incomplete spinal cord injury using an implanted FES system: a case report." Journal of Rehabilitation Research & Development, 44(3).[^21][^22]

3. **Bailey et al. (2010):** "Neuroprosthetic and neurotherapeutic effects of implanted electrical stimulation for ambulation after incomplete spinal cord injury." Journal of Rehabilitation Research & Development, 47(1): 7-16.[^25]

4. **Triolo et al.:** Multiple publications on implanted FES systems and clinical outcomes[^26]

5. **Peckham et al. (2001):** "Efficacy of an implanted neuroprosthesis for restoring hand grasp in tetraplegia: a multi-center study." Arch Phys Med Rehabil, 82: 1380-1388.[^27]

---

## 3. Vienna FES System

### Overview
**Developer:** Department of Biomedical Engineering and Physics, University of Vienna
**Commercialization:** Ottobock Healthcare GmbH, Austria
**Lead Researcher:** M. Bijak and colleagues

### Technical Specifications

#### System Configuration
- **Channels:** 8-channel stimulation system (for lower extremities)[^28][^29]
- **Variants:**
  - 8-channel (2nd generation): Clinical use for paraplegic mobilization and phrenic pacing
  - 20-channel (2nd generation): Tested in animal studies for paraplegic mobilization
  - 8-channel (3rd generation): Tested in animal studies for cardiac assist[^30]

#### System Components (for paraplegic stepping)
- 2 four-channel stimulation modules
- Central unit with battery and power management circuitry
- Communication control circuitry
- Wireless remote control unit
- Palmtop computer (main control and input device)[^28]
- PC software (Windows) for designing and optimizing stimulation sequences in rehabilitation center[^28]

#### Key Features
- **Modularity:** Easily adaptable for other FES applications[^28]
- **Wide parameter range:** Application-specific parameter optimization[^28]
- **Customization:** Allows customization of stimulation sequences[^29]
- **User-Friendly:** Easy handling with short sequence creation time[^28]

#### Stimulation Parameters for Denervated Muscles
- **Pulse Width:** 10-300 ms (biphasic long-duration impulses)
- **Amplitude:** Up to ±100V or ±250mA
- **Waveform:** Biphasic[^30]

### Clinical Outcomes

#### Walking Distance (Bijak et al., 2005)
- **Study Population:** 12 paraplegic individuals
- **Results:** Overground walking distances from 4 to 60 m[^29][^31]
- **System Used:** Vienna FES System (Ottobock Healthcare GmbH, Austria)

#### User Experience
First tests with patients familiar with FES showed:
- Smoother movements during stepping
- Acceptable handling
- Rapid stimulation sequence creation with PC software[^28]

### Comparison with Other Systems

When compared with multichannel FES systems:
- 16-channel systems: Walking speeds from 0.1 m/s to 0.5 m/s with maximum distance 34 m[^19][^20]
- 8-channel systems: Maximum speed 0.1 m/s with stride length <0.3 m[^20]
- Vienna 8-channel system performance falls within this range with 4-60 m distances[^29]

### Current Availability
- **Commercialization:** Through Ottobock Healthcare GmbH
- **Related Products:** Ottobock offers various FES solutions including:
  - Bioness L300 Go and L100 for foot drop and walking improvement[^32]
  - ActiGait implantable peroneal nerve stimulator (discussed separately)[^32]
  - MyGait system (launched 2013): First double-channel wireless surface stimulator[^32]

### Manufacturing Partners
- Ottobock Healthcare GmbH (Austria)
- Schuhfried Medizintechnik GmbH (stimulator development)[^30]

### Regulatory Status
- **CE Mark:** Approved for European market
- **FDA Status:** Not FDA approved in United States
- **Availability:** Primarily available in Europe through Ottobock

---

## 4. Commercial Exoskeletons

### Overview
Robotic exoskeletons represent an alternative to FES for restoring walking function. Unlike FES systems that activate paralyzed muscles, exoskeletons provide external mechanical support and power.

### FDA-Approved Personal Exoskeletons

#### ReWalk Personal Exoskeleton (Lifeward)

**FDA Approval:**
- **First Approval:** 2014 (first FDA approval for home and community use)[^33]
- **Stair Clearance:** 2023 (FDA clearance for stairs and curb functionality)[^34]

**Indications:**
- Spinal cord injury levels: T7-L5[^34]

**Key Features:**
- Only personal exoskeleton enabling access to stairs and curbs[^34]
- Longest battery life: 8 hours[^34]
- Two customizable walking speeds for indoor/outdoor transitions[^34]
- Enables transitions between sitting, standing, and walking

**Performance:**
- Walking speed: 0.26 m/s (mean)[^35]

**Medicare Coverage (2024):**
- **Classification:** Brace benefit category (effective January 1, 2024)[^36]
- **HCPCS Code:** K1007
- **Preliminary Payment:** $94,617 (proposed November 2023)[^37][^38]
- **Final Payment:** $91,032 (effective April 1, 2024)[^39]
- **First Claim Paid:** January 2024[^40]
- **Patient Responsibility:** 20% copay (approximately $18,200)

**Pricing:**
- **Retail:** >$100,000 (average)[^41]
- **Medicare Rate:** $91,032[^39]

#### Ekso Indego Personal (Ekso Bionics)

**FDA Approval:**
- **Date:** 2016 (for home use)[^33]

**Indications:**
- Spinal cord injury levels: T3-L5[^34]
- Not intended for sports or stair climbing[^34]

**Key Features:**
- Lightest commercial exoskeleton: 29 lbs (13 kg)[^42]
- Only exoskeleton with modular quick-connect design[^42]
- Can put on and take off without assistance[^42]
- Battery life: 4 hours[^34]

**Performance:**
- Walking speed: 0.31 m/s (mean)[^35]

**Medicare Coverage (2024):**
- **Final Payment:** $91,031.93 (effective April 1, 2024)[^43]
- **HCPCS Code:** K1007
- **First Reimbursement:** August 20, 2024[^43]

**VA Coverage:**
- Available to qualified veterans at no cost for home and community use[^43]

**Pricing:**
- **Retail:** >$100,000 (average)[^41]
- **Medicare Rate:** $91,032[^43]

#### EksoNR (Rehabilitation Only - Not Personal Use)

**FDA Clearance:**
- Only FDA-cleared exoskeleton for brain injury and MS[^44]
- First exoskeleton cleared for both stroke and SCI[^44]

**Use:** Clinical rehabilitation settings only (not for home use)

### Other Commercial Exoskeletons (Not FDA-Approved for Home Use)

#### Ekso GT
- **Performance:** Walking speed 0.14 m/s (mean)[^35]
- **Use:** Clinical rehabilitation settings

#### WPAL (Wearable Power Assist Locomotion)
- **Manufacturer:** Fujita Health University, Japan
- **Performance:** Walking speed 0.16 m/s (mean)[^35]

### FES vs Exoskeleton Comparison

#### How Exoskeletons Differ from FES

**Exoskeletons:**
- Provide external mechanical power via robotic joints[^45]
- Replace lost function rather than restore intrinsic function[^46]
- No muscle activation (no exercise benefit)[^46]
- More predictable and reliable control[^46]
- Easier to control than FES[^46]
- No muscle fatigue issues
- Higher upfront cost but potentially lower maintenance
- Heavier and more mechanically complex

**FES Systems:**
- Activate paralyzed muscles as natural actuators[^46]
- Restore intrinsic function and provide muscle exercise[^46]
- Health benefits from muscle activation (cardiovascular, bone density, reduced spasticity)
- Early muscle fatigue is major limitation[^46]
- More difficult to control joint trajectories[^46]
- Lighter weight (surface systems)
- Lower equipment cost for surface systems
- Daily electrode placement required (surface systems)

### Health Benefits of Exoskeleton Use

Clinical evidence for exoskeleton-assisted walking includes:
- Reduced pain and spasticity[^47]
- Improved bowel function[^47]
- Enhanced mood and quality of life[^47]
- Cardiovascular exercise benefits
- Potential reduction in secondary complications of SCI

### Accessibility Challenges

**Cost Barriers:**
- Average price >$100,000 makes devices cost-prohibitive for most SCI consumers[^41]
- Medicare coverage (2024) significantly improves access for qualifying beneficiaries
- 20% copay (~$18,200) still substantial burden
- Secondary insurance may cover copay[^43]

**Eligibility Requirements:**
- Specific SCI levels (varies by device)
- Adequate bone density
- Sufficient upper body strength and trunk control
- Range of motion requirements
- Height and weight restrictions
- Medical clearance required

---

## 5. Other FES Walking Systems

### 5.1 Commercial FES Foot Drop Devices

While not full walking systems, these devices assist with foot drop and gait improvement:

#### Bioness L300 Go System

**FDA Clearance:**
- **Date:** January 27, 2017[^48]
- **Regulation:** 21 CFR 882.5810 (External Functional Neuromuscular Stimulator)
- **Classification:** Class II medical device[^48]

**Indications:**
- Provide ankle dorsiflexion in adult and pediatric individuals with foot drop
- Assist knee flexion or extension in adults with muscle weakness
- Related to upper motor neuron disease/injury (stroke, SCI)[^48]

**Technical Specifications:**
- **Channels:** Multi-channel (dual-channel using single electrode)[^49][^50]
- **Sensors:** 3-axis gyroscope and accelerometer for 3D motion detection[^49]
- **Detection:** Adaptive learning algorithm accommodates gait dynamics changes[^49]
- **Response Time:** High-speed processor deploys stimulation within 10 milliseconds[^49]
- **Barefoot Capable:** Can be used without gait sensor[^49]

**System Components:**
- Stimulator cuff (fits below knee with integrated electrodes)
- Gait sensor (placed in shoe to detect heel-off/heel-on)
- Wireless remote control unit[^50]

**Key Features:**
- First FES system with 3D motion detection[^49]
- Balanced dorsiflexion with fine control of supination/pronation[^49]
- Two stimulation channels from single electrode[^49][^50]

**Pricing:**
- UK: £4,500-£5,000 (~$5,700-$6,300 USD)
- Includes assessment, fitting, follow-up, and electrode supplies[^51]
- US pricing varies by provider and insurance

**Current Distributor:**
- Ottobock (exclusive distributor for Bioness products)[^51]

#### WalkAide System

**Manufacturer:** Hanger Inc. (formerly Innovative Neurotronics)
**FDA Status:** FDA-approved[^52]

**Technical Specifications:**
- **Channels:** Single-channel
- **Target:** Common peroneal nerve and tibialis anterior muscle[^52]
- **Sensors:** Tilt sensor or heel sensor for gait synchronization[^52]

**Key Feature:**
- Used without shoe sensor since market introduction[^53]
- Competitive alternative to L300 system

#### NESS L300/L100 Systems

**Distributor:** Ottobock
**Availability:** Primarily European market

**L100 System:**
- Single-channel foot drop stimulator
- Basic functionality for ankle dorsiflexion

**L300 System:**
- Multi-channel capability
- Optional thigh cuff for knee instability[^51]
- Surface electrodes within cuff deliver nerve stimulation[^51]

#### Odstock Dropped Foot Stimulator

**Availability:** Available in multiple markets
**Type:** Single-channel peroneal nerve stimulator
**Use:** Foot drop assistance during walking

### 5.2 Implantable FES Devices

#### ActiGait (Ottobock)

**Device Type:** 4-channel semi-implantable peroneal nerve stimulator[^54][^55]

**Technical Specifications:**
- **Channels:** 4 independent channels[^54][^55]
- **Target:** Peroneal nerve (direct nerve stimulation)
- **Control:** Closed-loop system with sensor feedback[^54]
- **Electrodes:** Implanted nerve cuff around peroneal nerve

**Indications:**
- Drop foot from first motor neuron lesion:
  - Stroke
  - Multiple sclerosis
  - Tumors[^56]

**Contraindications:**
- Peripheral nerve injuries (diabetic polyneuropathy, ischemic nerve injury)
- Nerve root impairment[^56]

**Clinical Evidence:**
Superior to AFO (ankle-foot orthosis) in:[^57]
- Knee stability
- Ankle plantarflexion power
- Propulsion
- Step length symmetry
- Maximum paretic ankle plantarflexion
- Higher paretic peak ankle power

**Patient Satisfaction:**
- High satisfaction on COPM (Canadian Occupational Performance Measure)
- Self-perceived performance improvements
- Satisfaction with performance maintained long-term[^58]

**Regulatory Status:**
- **CE Mark:** 2006 (European market)[^59]
- **Current Availability:** Commercially unavailable as of recent reports[^60]
- **Historical Use:** Approximately 400 post-stroke patients implanted as of July 2015[^59]

**Safety and Efficacy:**
- Shown to be safe and effective in post-stroke patients[^59]
- Long-term reliability demonstrated[^58]
- High patient satisfaction scores[^58]

### 5.3 Historical FES Systems

#### Freehand System (NeuroControl Corporation)

**Device Type:** Implantable upper extremity neuroprosthesis
**Target Function:** Hand grasp restoration in tetraplegia
**FDA Status:** FDA-approved (no longer commercially available)[^52]

**Target Population:**
- C5 and C6 level tetraplegics[^61][^62]
- First implanted: 1986[^62]
- Total implanted: >250 individuals[^62]

**System Components:**
- Implanted receiver/stimulator (placed in chest wall)
- 8 electrode leads to forearm and hand[^63]
- External shoulder position sensor
- External control unit
- Skin-mounted coil for power and control signals[^63]

**Control Method:**
- Voluntary movement of contralateral shoulder measured by sensor
- Hand opening/closure proportional to shoulder movement distance
- Button press for selecting palmar vs lateral grasp[^63]

**Clinical Outcomes:**
- **Pre-implant grip strength:** Near zero
- **Post-implant (initial):**
  - Lateral grasp: 11.2N (mean)
  - Palmar grasp: 9.5N (mean)
  - Five-finger grasp: 10.4N (mean)
- **At 1 year:**
  - Lateral grasp: 15.2N (mean)
  - Palmar grasp: 10.4N (mean)
  - Five-finger grasp: 14.7N (mean)[^64]

**Usage:**
- 7 of 9 subjects used device daily[^64]
- Provided useful hand function not achievable otherwise[^64]

**Current Status:**
- NeuroControl Corporation closed (financial reasons)[^65]
- 1st generation no longer available[^66]
- Cleveland FES Center continues support for existing users[^65]
- Cleveland FES Center developing next-generation device[^65]

---

## 6. Novel Research Approaches

### 6.1 Brain-Spine Interface (BSI)

**Research Team:** Grégoire Courtine and Jocelyne Bloch
**Institution:** NeuroRestore (Lausanne University Hospital, EPFL)
**Publication:** Nature, May 2023[^67][^68]

#### Breakthrough Achievement
First demonstration of wireless brain-spine interface enabling natural walking in person with chronic tetraplegia.

#### How BSI Works

**System Components:**
1. **Brain Recording Devices:** Two implants on cerebral cortex (regions controlling left and right lower limb movement intentions)[^69]
2. **Spinal Stimulation:** Paddle lead on lumbar spinal cord[^69]
3. **Digital Bridge:** Wireless interface transforming thought into action[^70]

**Mechanism:**
- Records cortical signals related to movement intention
- Processes signals in real-time
- Modulates epidural electrical stimulation (EES) targeting spinal walking circuits
- Establishes direct brain-to-spinal cord communication[^67][^68]

#### Clinical Results

**Participant Profile:**
- Gert-Jan, 40 years old
- Chronic tetraplegia from bicycle accident
- Previously participated in STIMO trial (EES only)
- Reached plateau with stimulation-only approach[^71]

**BSI Performance:**
- **Calibration:** Highly reliable BSI calibrated within minutes[^72]
- **Stability:** Remained stable over 1 year, including independent home use[^72]
- **Control:** Natural control for standing, walking, stair climbing, complex terrains[^72]
- **Dependence:** Instant loss of stepping when BSI turned off; immediate resumption when on[^72]

**Neurological Recovery:**
After 40 neurorehabilitation sessions:
- Could walk with crutches even with implant OFF[^73]
- Improvements in all conventional clinical assessments[^73]
- Quality-of-life improvements:
  - Independent walking around house
  - Getting in/out of car
  - Standing at bar with friends[^73]

#### Future Directions
- Tested in only one person to date (as of 2023)[^74]
- Potential for arm and hand function restoration[^74]
- Applications for stroke paralysis[^74]
- Commercial development:
  - ONWARD Medical leading commercialization
  - Support from European Commission (EIC)
  - Goal: worldwide availability[^74]

### 6.2 Hybrid FES-Exoskeleton Systems

**Concept:** Combining FES muscle activation with robotic exoskeleton support[^75][^76]

#### Advantages of Hybrid Approach

**Overcomes FES Limitations:**
- Reduces early muscle fatigue issues[^77]
- Improves control of joint trajectories[^77]
- Provides backup support when muscles fatigue

**Overcomes Exoskeleton Limitations:**
- Uses muscle power to reduce energy demand[^78]
- Requires less powerful (lighter) joint actuators[^78]
- Provides muscle exercise and health benefits[^46]
- Promotes more effective neural plasticity than standard treadmill training[^78]

**Combined Benefits:**
- Natural muscle actuation where possible[^77]
- Mechanical support where needed
- Potential for lighter overall system[^78]
- Better rehabilitation outcomes through neuroplasticity

#### Research Status

**Experimental Systems:**
- Tested on healthy subjects and paraplegic patients[^79]
- Good control performance demonstrated:
  - Torque distribution
  - Trajectory tracking
  - Phase synchronization[^79]

**Development Challenges:**
- Complexity of coordinating two systems
- Control algorithms for optimal FES/exoskeleton balance
- Real-time adaptation to muscle fatigue
- System weight and portability
- Cost of combined system

**Research Groups:**
- Multiple academic institutions worldwide
- No commercially available hybrid systems yet
- Continued research showing promise

### 6.3 Closed-Loop FES Walking Systems

**Goal:** Automatic adjustment of stimulation based on sensor feedback

#### Key Research Developments

**Motion Sensor-Driven Control (University of Sydney, University of Malaya):**[^80][^81]

**System Design:**
- Finite-state controller
- Four miniaturized motion sensors for kinematic feedback
- Automated control of:
  - Knee extension (quadriceps and gluteus) during stance phase
  - Common peroneal nerve stimulation during swing phase

**Advantages:**
- Required less user intervention than open-loop[^82]
- Accounted for inter-subject differences in stimulation requirements[^82]
- Resolved issues with varying gait dynamics[^81]

**Pilot Study Results (2 complete paraplegic subjects):**
- Successfully ameliorated drawbacks of open-loop systems[^82]
- Less continuous user attention required
- Better adaptation to individual needs

#### Multimodal Closed-Loop Strategies (2024-2025)

**Integration Approaches:**[^83][^84]
- Robot-assisted gait training (RAGT) + spinal cord electrical stimulation
- Benefits for locomotor and autonomic functions
- EEG-based decoding of lower limb movements
- Combination with epidural electrical stimulation (EES)

**2024 Research:**
- EEG successfully decoded key lower limb movements in chronic SCI patient with EES implant[^85]

#### Control Algorithm Research

**Tested Approaches:**[^86]
- Proportional-integral-derivative (PID) control
- Gain scheduling
- Sliding mode control

**Challenges Identified:**
- Significantly degraded performance with real-world effects:
  - Muscle fatigue[^86]
  - Spasms[^86]
- Sensitivity to variation in muscle recruitment function parameters[^86]
- Parameters change during real-world FES use[^86]

#### Current Limitations

**Finite-State Controllers:**
- Input resolution too low for real-time fatigue compensation[^87]
- Cannot provide fine-grained modulation of stimulation parameters

**Practical Implementation:**
- Few stable closed-loop systems developed beyond research[^9]
- Lack of practicality has impeded progress[^8]
- May improve with implanted sensor systems[^8]
- Deterministic rule sets from motion sensor feedback show promise[^8]

---

## 7. Key Limitations and Challenges

### 7.1 Muscle Fatigue

#### The Core Problem
Muscle fatigue is the primary limitation of all FES walking systems.[^88][^89]

**Characteristics:**
- Rapid onset compared to voluntary contractions[^90]
- Decay in peak force for given stimulation input[^89]
- Changes stimulation intensity-force relationship during use[^88]

**Contributing Factors:**
1. **Reverse recruitment order:** FES recruits motor units opposite to physiological size principle[^90]
2. **Nonselective recruitment:** All motor units recruited simultaneously rather than sequentially[^90]
3. **Synchronous activation:** Motor units activated synchronously rather than asynchronously[^90]
4. **Spatially fixed pattern:** Same motor units stimulated repeatedly[^90]

#### Impact on Performance
- Limits walking duration and distance
- Requires rest periods during use
- Reduces effectiveness over time within single session
- Makes long-distance ambulation impractical

#### Mitigation Strategies

**Stimulation Parameter Optimization:**
- Lower frequencies preferred to avoid fatigue (25 Hz optimal)[^91]
- Intermittent high-frequency > low-frequency repetitive stimulation[^92]
- Apply FES intermittently in specific gait phases[^92]
- Variations in pulse pattern and number have little influence[^92]

**Control Strategies:**
- Adaptive closed-loop control to adjust for fatigue[^9]
- Assist-as-needed approaches[^93]
- Iterative learning control (ILC) to reduce fatigue[^94]

**System Design:**
- Hybrid FES-exoskeleton to share load[^78]
- Rotation of stimulated muscle groups
- Implanted systems for better muscle selectivity

### 7.2 Control Challenges

#### Open-Loop Control Limitations

**No Feedback Compensation:**
- Cannot adjust for changes in muscle response[^95]
- No compensation for fatigue or spasms[^95]
- Cannot adapt to environmental changes[^95]

**User Burden:**
- Requires continuous attention[^7][^8]
- Frequent button pressing needed[^7]
- Mistiming causes abnormal muscle synchronization[^7]
- Hands occupied with control (cannot use for balance support fully)[^7]
- Errors can cause falls[^7]

#### Closed-Loop Control Challenges

**Electromechanical Delay (EMD):**
- Increases significantly with fatigue[^96]
- Causes instability in closed-loop control[^96]
- Time-varying nature makes control difficult[^96]

**Nonlinear Muscle Response:**
- Muscle recruitment curve is nonlinear and time-varying[^96]
- Depends on fatigue evolution[^97]
- Makes precise control difficult

**Sensor Requirements:**
- Critical choice of sensor type[^97]
- Must provide adequate resolution for real-time modulation[^87]
- Balance between complexity and practicality

**Implementation Barriers:**
- Few stable systems developed[^9]
- Lack of practicality for daily use[^8]
- Setup time longer than open-loop systems[^8]

### 7.3 Limited Selectivity of Surface Stimulation

**Challenges:**
- Cannot directly stimulate deep muscles (e.g., hip flexors)[^11][^23]
- Recruit multiple muscles simultaneously (less selective)
- Variable electrode contact with skin movement
- Daily electrode placement variability
- Skin irritation with prolonged use

**Solutions:**
- Implanted electrodes provide better selectivity[^11][^23]
- Nerve cuff electrodes for fascicle-specific activation[^16]
- Intramuscular electrodes for deep muscle access[^16]

### 7.4 Incomplete Hip Flexion

**Problem:**
Surface FES systems cannot directly activate hip flexor muscles (iliopsaus, rectus femoris)[^11]

**Current Approach:**
- Rely on flexion withdrawal reflex (stimulating peroneal nerve)[^5][^7]
- Results in:
  - Less controlled hip flexion
  - Variable response between individuals
  - Scissoring gait patterns[^20]
  - Limited forward progression[^20]

**Solution:**
- Implanted electrodes can directly stimulate iliopsoas and sartorius[^19][^21][^22]
- Provides more natural hip flexion
- Improves gait quality and speed

### 7.5 Training Requirements

**Extensive Time Investment:**
- Parastep: 32 sessions required[^1]
- Implanted systems: 12+ weeks typical[^21][^22]
- Must be performed by specially trained therapists[^1]

**Barriers to Adoption:**
- Time commitment substantial
- Requires specialized facilities
- Therapist training needed
- Geographic access limitations
- Cost of training (may or may not be covered by insurance)

### 7.6 Regulatory and Access Barriers

#### Limited Commercial Availability

**Surface FES Walking Systems:**
- Only Parastep FDA-approved in US[^3][^4]
- Parastep sales limited (~550 units over 20 years)[^5]

**Implanted FES Walking Systems:**
- None FDA-approved for commercial use[^4]
- Available only in research studies[^24]
- Limited to specific research centers

**Foot Drop Devices:**
- Multiple FDA-approved options (L300 Go, WalkAide)[^48][^52]
- Better availability but limited to foot drop only

#### Cost Barriers

**FES Systems:**
- Parastep: Cost not publicly disclosed, but covered by Medicare at 80%[^5]
- Implanted research systems: Experimental, typically no cost to research participants

**Exoskeletons:**
- Retail: >$100,000[^41]
- Medicare coverage: $91,032 (started 2024)[^39][^43]
- Patient copay: ~$18,200 (20%)
- Still prohibitively expensive for many SCI consumers[^41]

### 7.7 Performance Limitations

#### Walking Speeds

All FES and exoskeleton systems achieve speeds well below normal walking (1.2-1.4 m/s):

**FES Systems:**
- Parastep (open-loop surface): 6-9 m typical distance[^7]
- 16-channel implanted: 0.1-0.5 m/s[^19][^20]
- 8-channel implanted: 0.02-0.2 m/s[^20][^21]
- Vienna FES: 4-60 m distance[^29]

**Exoskeletons:**
- ReWalk: 0.26 m/s[^35]
- Indego: 0.31 m/s[^35]
- Ekso GT: 0.14 m/s[^35]
- WPAL: 0.16 m/s[^35]

**Implications:**
- Slow speeds limit practical community ambulation
- Energy expenditure high relative to distance covered
- Primarily suitable for short distances
- Not competitive with wheelchair mobility for most uses

#### Walking Distance

**Limited Endurance:**
- Muscle fatigue restricts distance
- Energy cost high for user
- Rest periods needed
- Typically <100 m for most systems and users

### 7.8 Research-to-Practice Gap

**Problem:**
Despite decades of research and promising results, few FES walking systems available outside research laboratories.[^98]

**Contributing Factors:**
1. **Complexity:** Systems difficult to implement in clinical settings
2. **Cost:** High development and implementation costs
3. **Training:** Specialized expertise required
4. **Reliability:** Real-world performance varies significantly
5. **Regulatory:** Lengthy and expensive FDA approval process
6. **Commercial viability:** Limited market size, high costs
7. **User expectations:** Performance doesn't meet hoped-for functionality for many users

### 7.9 Individual Variability

**Challenges:**
- Response to FES varies significantly between individuals[^82]
- Optimal stimulation parameters differ by person
- Muscle recruitment characteristics vary
- Spasticity and spasms unpredictable
- Bone density and joint health vary
- Motivation and training compliance differ

**Implications:**
- Extensive individualized tuning required
- One-size-fits-all approaches ineffective
- Ongoing adjustments needed over time
- Some individuals may not achieve functional walking despite system use

---

## 8. Academic Research Groups Working on Closed-Loop FES

### 8.1 University of Waterloo (Canada)
**Researchers:** Lora Giangregorio and colleagues
**Department:** Kinesiology
**Focus:** FES-assisted walking in incomplete SCI[^99]

**Research Contributions:**
- Closed-loop visual-feedback balance training (VFBT) with FES
- Standing balance rehabilitation
- Body composition effects of FES walking

### 8.2 University of Sydney (Australia) & University of Malaya (Malaysia)
**Institutions:**
- Clinical Exercise and Rehabilitation Unit, University of Sydney
- Biomedical Engineering Department, University of Malaya[^80][^81]

**Key Developments:**
- Novel closed-loop FES-gait control system
- Finite-state controller with motion sensor feedback
- Four miniaturized motion sensors for kinematic feedback
- Automated control of stance and swing phases

**Pilot Study Results:**
- Tested on two sensorimotor complete paraplegic subjects
- Reduced user intervention vs. open-loop
- Accounted for inter-subject differences[^82]

### 8.3 University of Alberta (Canada)
**Department:** Physical Therapy, Edmonton
**Focus:** Muscle models for FES system improvement[^100]

### 8.4 Università Vita Salute San Raffaele & Scuola Superiore Sant'Anna (Italy)
**Laboratory:** Modular Implantable Neurotechnologies (MINE)
**Location:** Milan, Italy[^101]

**Research Focus:**
- Multimodal closed-loop strategies for gait recovery
- Integration of robotic assistance and neuromodulation
- Personalized and physiological gait recovery
- Capitalizing on residual motor activity
- Neuroplasticity and motor relearning

### 8.5 NeuroRestore (Switzerland)
**Institutions:**
- Lausanne University Hospital
- EPFL (École Polytechnique Fédérale de Lausanne)

**Key Researchers:**
- Grégoire Courtine
- Jocelyne Bloch[^67][^68]

**Major Breakthrough:**
- Brain-spine interface (BSI) for walking after tetraplegia
- Published in Nature (May 2023)
- First demonstration of thought-controlled walking via digital bridge

**Commercialization Partner:**
- ONWARD Medical (developing commercial version)[^74]

### 8.6 Cleveland FES Center (USA)
**Institutions:**
- Cleveland VA Medical Center
- Case Western Reserve University
- MetroHealth Medical Center

**Key Researchers:**
- Dr. Hunter Peckham
- Dr. Ronald J. Triolo
- Dr. Rudi Kobetic[^13]

**Major Contributions:**
- Networked Neuroprosthetic (NNP) System
- Implanted electrode technologies
- IST-12 stimulator-telemeter
- Freehand System (upper extremity)
- Decades of implanted FES walking research

### 8.7 Recent Research Directions (2024-2025)

**Emerging Approaches:**

1. **EEG-Based Control:**
   - Decoding lower limb movements from brain signals
   - Integration with epidural electrical stimulation
   - Chronic SCI applications[^85]

2. **Multimodal Integration:**
   - Robot-assisted gait training + neuromodulation
   - Benefits for locomotor and autonomic functions[^83][^84]

3. **Advanced Control Algorithms:**
   - Assist-as-needed control for foot drop[^93]
   - Adaptive reflexive control strategies[^102]
   - Iterative learning control (ILC) for fatigue reduction[^94]

4. **Sensor Technology:**
   - Miniaturized motion sensors
   - Improved gait phase detection
   - Reduced detection delay compensation[^103]

5. **Brain-Computer Interfaces:**
   - Brain-spine interfaces for walking
   - Thought-controlled FES activation
   - Natural control restoration[^67][^68]

---

## References

[^1]: Christopher Reeve Foundation. (2024). "ParaStep." National Paralysis Resource Center. https://www.christopherreeve.org/wp-content/uploads/2024/05/ParaStep-1-24-A.pdf

[^2]: Sigmedics Inc. "Parastep I™ FAQ." https://www.sigmedics.com/faq

[^3]: FEP Blue. (2024). "Functional Neuromuscular Electrical Stimulation." Medical Policy Manual. https://www.fepblue.org/-/media/PDFs/Medical-Policies/2024/June/June-2024-Medical-Policies/Remove--Replace/80301-Functional-Neuromuscular-Electrical.pdf

[^4]: Molina Healthcare. "Functional Electrical Stimulation for Spinal Cord Injury Policy." https://www.molinaclinicalpolicy.com/molinaclinicalpolicy/-/media/Molina/PublicWebsite/PDF/Common/Molina-Clinical-Policy/Functional-Electrical-Stimulation-for-Spinal-Cord-Injury_R.pdf

[^5]: Blue Shield of California. (2023). "Functional Neuromuscular Stimulation." https://www.blueshieldca.com/content/dam/bsca/en/provider/docs/2023/May/PRV_Func_NeuroMuscStim.pdf

[^6]: Molina Healthcare. "Functional Electrical Stimulation for Spinal Cord Injury." https://www.molinahealthcare.com/-/media/Molina/PublicWebsite/PDF/Providers/oh/medicaid/policies/MCP-205-Functional-Electrical-Stimulation-for-Spinal-Cord-Injury.pdf

[^7]: ScienceDirect. "Functional Electrical Stimulation Control of Standing and Stepping After Spinal Cord Injury: A Review of Technical Characteristics." https://www.sciencedirect.com/science/article/abs/pii/S1094715910600359

[^8]: Kapadia et al. (2016). "A novel motion sensor-driven control system for FES-assisted walking after spinal cord injury: A pilot study." ScienceDirect. https://www.sciencedirect.com/science/article/abs/pii/S1350453316301217

[^9]: PMC. "Sensing and Control Strategies Used in FES Systems Aimed at Assistance and Rehabilitation of Foot Drop: A Systematic Literature Review." https://pmc.ncbi.nlm.nih.gov/articles/PMC11355777/

[^10]: PMC. "Evaluation of Gait Phase Detection Delay Compensation Strategies to Control a Gyroscope-Controlled Functional Electrical Stimulation System During Walking." https://pmc.ncbi.nlm.nih.gov/articles/PMC6603781/

[^11]: ScienceDirect. "Functional Electrical Stimulation - an overview." https://www.sciencedirect.com/topics/medicine-and-dentistry/functional-electrical-stimulation

[^12]: PMC. "Strategies for Rapid Muscle Fatigue Reduction during FES Exercise in Individuals with Spinal Cord Injury: A Systematic Review." https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0149024

[^13]: Cleveland FES Center. "Cleveland FES Center's Networked Neural Prosthesis." https://www.implantable-device.com/2013/08/24/cleveland-fes-centers-networked-neural-prosthesis/

[^14]: Cleveland FES Center. "Networked Neuroprosthetic (NNP) System." https://fescenter.org/research/technology-programs/networked-neuroprosthetic-nnp-system/

[^15]: Cleveland FES Center. "Cleveland FES Center's Networked Neural Prosthesis." https://fescenter.org/cleveland-fes-centers-networked-neural-prosthesis/

[^16]: Cleveland FES Center. "Implantable Electrode Design." https://fescenter.org/research/technology-programs/implantable-electrode-design/

[^17]: PubMed. "Design and testing of an advanced implantable neuroprosthesis with myoelectric control." https://pubmed.ncbi.nlm.nih.gov/20876029/

[^18]: PubMed. "An externally powered, multichannel, implantable stimulator-telemeter for control of paralyzed muscle." https://pubmed.ncbi.nlm.nih.gov/9556963/

[^19]: Kobetic, R., Triolo, R.J., & Marsolais, E.B. (1997). "Muscle selection and walking performance of multichannel FES systems for ambulation in paraplegia." IEEE Trans Rehabil Eng, 5(1): 23-29. https://pubmed.ncbi.nlm.nih.gov/9086382/

[^20]: University of South Dakota. "USD RED." https://red.library.usd.edu/cgi/viewcontent.cgi?article=1391&context=honors-thesis

[^21]: Hardin, E., Kobetic, R., Murray, L., Corado-Ahmed, M., Pinault, G., Sakai, J., Bailey, S.N., Ho, C., & Triolo, R.J. (2007). "Walking after incomplete spinal cord injury using an implanted FES system: A case report." https://www.rehab.research.va.gov/jour/07/44/3/hardin.html

[^22]: PubMed. "Walking after incomplete spinal cord injury using an implanted FES system: a case report." https://pubmed.ncbi.nlm.nih.gov/18247230/

[^23]: PMC. "Functional Electrical Stimulation and Spinal Cord Injury." https://pmc.ncbi.nlm.nih.gov/articles/PMC4519233/

[^24]: MSKTC. (2024). "Functional Electrical Stimulation (FES) for Spinal Cord Injury." https://msktc.org/sites/default/files/2024-05/SCI-FES-Factsheet-508.pdf

[^25]: Bailey, S.N., Hardin, E., Kobetic, R., Boggs, L., Pinault, G., & Triolo, R. (2010). "Neuroprosthetic and neurotherapeutic effects of implanted electrical stimulation for ambulation after incomplete spinal cord injury." Journal of Rehabilitation Research & Development, 47(1): 7-16.

[^26]: Nature. "Functional electrical stimulation after spinal cord injury: current use, therapeutic effects and future directions." Spinal Cord. https://www.nature.com/articles/3102091

[^27]: Peckham, P.H., Keith, M.W., Kilgore, K.L., Grill, J.H., Wuolle, K.S., & Thrope, G.B. (2001). "Efficacy of an implanted neuroprosthesis for restoring hand grasp in tetraplegia: a multi-center study." Arch Phys Med Rehabil, 82: 1380-1388.

[^28]: Bijak, M. et al. (2002). "The Vienna functional electrical stimulation system for restoration of walking functions in spastic paraplegia." Artificial Organs. https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1525-1594.2002.06935.x

[^29]: ScienceDirect. "A novel motion sensor-driven control system for FES-assisted walking after spinal cord injury: A pilot study." https://www.sciencedirect.com/science/article/abs/pii/S1350453316301217

[^30]: University of Vienna. "15. Vienna Workshop on FES 2025." https://mpbmt.meduniwien.ac.at/fileadmin/content/OE/zmpbmt/Projekte/FES/JubileeProceedings/15.FESWorkshop2025_jub.pdf

[^31]: Review of VA Rehab. "Walking after incomplete spinal cord injury using an implanted FES system: A case report." https://www.rehab.research.va.gov/jour/07/44/3/hardin.html

[^32]: Ottobock. "Functional Electrical Stimulation." https://www.ottobock.com/en-gb/orthotics/functional-electrical-stimulation

[^33]: Christopher & Dana Reeve Foundation. "Personal Exoskeletons." https://www.christopherreeve.org/todays-care/living-with-paralysis/rehabilitation/personal-exoskeletons/

[^34]: PMC. "Clinician-Focused Overview of Bionic Exoskeleton Use After Spinal Cord Injury." https://pmc.ncbi.nlm.nih.gov/articles/PMC5562031/

[^35]: Exoskeleton Report. (2016). "Comparing Indego vs Ekso GT vs ReWalk, Researched by VAPAHCS." https://exoskeletonreport.com/2016/09/comparing-indego-vs-ekso-gt-vs-rewalk-researched-vapahcs/

[^36]: New Mobility. "Medicare to Cover Personal Exoskeletons." https://newmobility.com/medicare-to-cover-personal-exoskeletons/

[^37]: Lifeward. "In Historic Move, Medicare Proposes Preliminary Reimbursement Level for ReWalk Personal Exoskeleton." https://ir.rewalk.com/news-releases/news-release-details/historic-move-medicare-proposes-preliminary-reimbursement-level

[^38]: O&P EDGE. "CMS Proposes Reimbursement Level for ReWalk Exoskeleton." https://opedge.com/cms-proposes-reimbursement-level-for-rewalk-exoskeleton/

[^39]: Lifeward. "Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton." https://ir.golifeward.com/news-releases/news-release-details/medicare-revises-2024-fee-schedule-include-payment-rate-rewalk

[^40]: Lifeward. "First ReWalk Personal Exoskeleton Claim Paid by Medicare." https://ir.rewalk.com/news-releases/news-release-details/first-rewalk-personal-exoskeleton-claim-paid-medicare

[^41]: Cost Charts. "How Much Does an Exoskeleton Cost?" https://costcharts.com/exoskeleton/

[^42]: Ekso Bionics. "Gain Independence with Ekso Indego Personal." https://eksobionics.com/ekso-indego-personal/

[^43]: Ekso Bionics. "Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from CMS for Ekso Indego Personal." https://ir.eksobionics.com/press-releases/detail/756/ekso-bionics-receives-final-payment-determination-for

[^44]: Ekso Bionics. "Home." https://eksobionics.com

[^45]: PMC. "Review of hybrid exoskeletons to restore gait following spinal cord injury." https://pubmed.ncbi.nlm.nih.gov/22773254/

[^46]: Frontiers. "A Muscle-First, Electromechanical Hybrid Gait Restoration System in People With Spinal Cord Injury." https://www.frontiersin.org/journals/robotics-and-ai/articles/10.3389/frobt.2021.645588/full

[^47]: Lifeward. "ReWalk 7 Personal Exoskeleton for Spinal Cord Injury." https://golifeward.com/products/rewalkpersonal-exoskeleton/

[^48]: FDA. (2017). "March 9, 2018 Bioness, Inc." https://www.accessdata.fda.gov/cdrh_docs/pdf17/K173682.pdf

[^49]: PRNewswire. "Bioness Receives FDA Clearance for the L300 Go™ System." https://www.prnewswire.com/news-releases/bioness-receives-fda-clearance-for-the-l300-go-system-300402927.html

[^50]: Complete Balance Solutions. "Bioness L300 Go Foot Drop System." https://www.completebalancesolutions.com/technology/bioness/

[^51]: MS Trust. "Functional electrical stimulation (FES)." https://mstrust.org.uk/a-z/functional-electrical-stimulation-fes

[^52]: Cerebral Palsy Guidance. "Functional Electrical Stimulation." https://cerebralpalsyguidance.com/cerebral-palsy/treatment/functional-electrical-stimulation/

[^53]: Multiple Sclerosis News Today. (2017). "FAQs About the Bioness 'L300 Go' for Foot Drop." https://multiplesclerosisnewstoday.com/columns/2017/02/28/bioness-l300-go-foot-drop-faqs/

[^54]: PubMed. "Effects of implantable peroneal nerve stimulation on gait quality, energy expenditure, participation and user satisfaction in patients with post-stroke drop foot using an ankle-foot orthosis." https://pubmed.ncbi.nlm.nih.gov/26484694/

[^55]: PMC. "IMPLANTED PERONEAL NERVE STIMULATOR TREATMENT FOR DROP FOOT CAUSED BY CENTRAL NERVOUS SYSTEM LESION: A TWELVE-MONTH FOLLOW-UP OF 21 PATIENTS." https://pmc.ncbi.nlm.nih.gov/articles/PMC9252092/

[^56]: ScienceDirect. "New Therapeutic Option for Drop Foot with the ActiGait Peroneal Nerve Stimulator—a Technical Note." https://www.sciencedirect.com/science/article/abs/pii/S1878875015008669

[^57]: PubMed. "Kinematic and kinetic benefits of implantable peroneal nerve stimulation in people with post-stroke drop foot using an ankle-foot orthosis." https://pubmed.ncbi.nlm.nih.gov/29889089/

[^58]: Journal of Rehabilitation Medicine. "Implanted Peroneal Nerve Stimulator Treatment for Drop Foot Caused by Central Nervous System Lesion: A Twelve-Month Follow-up of 21 Patients." https://medicaljournalssweden.se/jrm/article/view/2164/6075

[^59]: PubMed. "New Therapeutic Option for Drop Foot with the ActiGait Peroneal Nerve Stimulator--a Technical Note." https://pubmed.ncbi.nlm.nih.gov/26164191/

[^60]: Frontiers. "Multimodal closed-loop strategies for gait recovery after spinal cord injury and stroke via the integration of robotics and neuromodulation." https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2025.1569148/full

[^61]: SCIRE Professional. "Freehand System." https://scireproject.com/evidence/upper-limb/complementary-and-alternative-medicine/freehand-system/

[^62]: NeuroTech Reports. "European Effort Seeks to Enhance Upper-Extremity FES." https://www.neurotechreports.com/pages/Upper-extremity-FES.html

[^63]: NeuroTech Reports. "Functional Electrical Stimulation systems." https://www.neurotechreports.com/pages/FES_Upper_Extremity_Systems.html

[^64]: Nature. "The functional impact of the Freehand System on tetraplegic hand function. Clinical Results." Spinal Cord. https://www.nature.com/articles/3101373

[^65]: Cleveland FES Center. "Pediatric Hand Grasp." https://fescenter.org/current-clinical-trials/pediatric-hand-grasp/

[^66]: ResearchGate. "[The Freehand System: an implantable neuroprosthesis for functional electrostimulation of the upper extremity]." https://www.researchgate.net/publication/11873330_The_Freehand_System_an_implantable_neuroprosthesis_for_functional_electrostimulation_of_the_upper_extremity

[^67]: Nature. (2023). "Walking naturally after spinal cord injury using a brain–spine interface." https://www.nature.com/articles/s41586-023-06094-5

[^68]: PubMed. "Walking naturally after spinal cord injury using a brain-spine interface." https://pubmed.ncbi.nlm.nih.gov/37225984/

[^69]: Physics World. "Brain–spine interface enables natural walking after spinal cord injury." https://physicsworld.com/a/brain-spine-interface-enables-natural-walking-after-spinal-cord-injury/

[^70]: NeuroRestore. "Walking naturally after spinal cord injury using a brain–spine interface." https://www.neurorestore.swiss/press-1/bci2023

[^71]: IFLScience. "Paralyzed Patient Walks Again Thanks To Breakthrough Implant Treatment." https://www.iflscience.com/paralyzed-patient-walks-again-thanks-to-breakthrough-implant-treatment-69074

[^72]: Neuroscience News. "Wireless Brain-Spine Interface: A Leap Towards Reversing Paralysis." https://neurosciencenews.com/sci-bci-23338/

[^73]: ResearchGate. "(PDF) Walking naturally after spinal cord injury using a brain–spine interface." https://www.researchgate.net/publication/371010014_Walking_naturally_after_spinal_cord_injury_using_a_brain-spine_interface

[^74]: PMC. "Brain–spine interfaces to reverse paralysis." https://pmc.ncbi.nlm.nih.gov/articles/PMC9522392/

[^75]: PMC. "Review of hybrid exoskeletons to restore gait following spinal cord injury." https://pubmed.ncbi.nlm.nih.gov/22773254/

[^76]: PMC. "A Muscle-First, Electromechanical Hybrid Gait Restoration System in People With Spinal Cord Injury." https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111011/

[^77]: VA Rehab. "Review of hybrid exoskeletons to restore gait following spinal cord injury." https://www.rehab.research.va.gov/jour/2012/494/page497.html

[^78]: PMC. "Cooperative Control for A Hybrid Rehabilitation System Combining Functional Electrical Stimulation and Robotic Exoskeleton." https://pmc.ncbi.nlm.nih.gov/articles/PMC5742598/

[^79]: PMC. "Cooperative Control for A Hybrid Rehabilitation System Combining Functional Electrical Stimulation and Robotic Exoskeleton." https://pmc.ncbi.nlm.nih.gov/articles/PMC5742598/

[^80]: PubMed. "A novel motion sensor-driven control system for FES-assisted walking after spinal cord injury: A pilot study." https://pubmed.ncbi.nlm.nih.gov/27346492/

[^81]: ScienceDirect. "A novel motion sensor-driven control system for FES-assisted walking after spinal cord injury: A pilot study." https://www.sciencedirect.com/science/article/abs/pii/S1350453316301217

[^82]: PubMed. "A novel motion sensor-driven control system for FES-assisted walking after spinal cord injury: A pilot study." https://pubmed.ncbi.nlm.nih.gov/27346492/

[^83]: PMC. "Multimodal closed-loop strategies for gait recovery after spinal cord injury and stroke via the integration of robotics and neuromodulation." https://pmc.ncbi.nlm.nih.gov/articles/PMC12310727/

[^84]: Frontiers. "Multimodal closed-loop strategies for gait recovery after spinal cord injury and stroke via the integration of robotics and neuromodulation." https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2025.1569148/full

[^85]: PMC. "Multimodal closed-loop strategies for gait recovery after spinal cord injury and stroke via the integration of robotics and neuromodulation." https://pmc.ncbi.nlm.nih.gov/articles/PMC12310727/

[^86]: PubMed. "A comparison of closed-loop control algorithms for regulating electrically stimulated knee movements in individuals with spinal cord injury." https://pubmed.ncbi.nlm.nih.gov/22772375/

[^87]: PMC. "An adaptive reflexive control strategy for walking assistance system based on functional electrical stimulation." https://pmc.ncbi.nlm.nih.gov/articles/PMC9450861/

[^88]: PubMed. "The Time-Varying Nature of Electromechanical Delay and Muscle Control Effectiveness in Response to Stimulation-Induced Fatigue." https://pubmed.ncbi.nlm.nih.gov/27845664/

[^89]: PMC. "Transcutaneous Functional Electrical Stimulation Controlled by a System of Sensors for the Lower Limbs: A Systematic Review." https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780889/

[^90]: PMC. "An adaptive reflexive control strategy for walking assistance system based on functional electrical stimulation." https://pmc.ncbi.nlm.nih.gov/articles/PMC9450861/

[^91]: PMC. "Sensing and Control Strategies Used in FES Systems Aimed at Assistance and Rehabilitation of Foot Drop: A Systematic Review." https://pmc.ncbi.nlm.nih.gov/articles/PMC11355777/

[^92]: PMC. "An adaptive reflexive control strategy for walking assistance system based on functional electrical stimulation." https://pmc.ncbi.nlm.nih.gov/articles/PMC9450861/

[^93]: arXiv. "Assist-as-needed Control for FES in Foot Drop Management." https://arxiv.org/html/2510.02808

[^94]: PMC. "An adaptive reflexive control strategy for walking assistance system based on functional electrical stimulation." https://pmc.ncbi.nlm.nih.gov/articles/PMC9450861/

[^95]: ScienceDirect. "Open-Loop Control System - an overview." https://www.sciencedirect.com/topics/engineering/open-loop-control-system

[^96]: PubMed. "The Time-Varying Nature of Electromechanical Delay and Muscle Control Effectiveness in Response to Stimulation-Induced Fatigue." https://pubmed.ncbi.nlm.nih.gov/27845664/

[^97]: PMC. "Transcutaneous Functional Electrical Stimulation Controlled by a System of Sensors for the Lower Limbs: A Systematic Review." https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780889/

[^98]: MSKTC. (2024). "Functional Electrical Stimulation (FES) for Spinal Cord Injury." https://msktc.org/sites/default/files/2024-05/SCI-FES-Factsheet-508.pdf

[^99]: PubMed. "A randomized trial of functional electrical stimulation for walking in incomplete spinal cord injury: effects on body composition." https://pubmed.ncbi.nlm.nih.gov/23031172/

[^100]: PubMed. "Can muscle models improve FES-assisted walking after spinal cord injury?" https://pubmed.ncbi.nlm.nih.gov/9680953/

[^101]: Frontiers. "Multimodal closed-loop strategies for gait recovery after spinal cord injury and stroke via the integration of robotics and neuromodulation." https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2025.1569148/full

[^102]: PMC. "An adaptive reflexive control strategy for walking assistance system based on functional electrical stimulation." https://pmc.ncbi.nlm.nih.gov/articles/PMC9450861/

[^103]: PMC. "Evaluation of Gait Phase Detection Delay Compensation Strategies to Control a Gyroscope-Controlled Functional Electrical Stimulation System During Walking." https://pmc.ncbi.nlm.nih.gov/articles/PMC6603781/
